about
Regulation of microsomal triglyceride transfer protein mRNA expression by endotoxin and cytokinesHemosuccus pancreaticus from a pseudoaneurysm of the hepatic artery proper in a patient with a pancreatic pseudocystImmunohistochemically proven cytomegalovirus end-organ disease in solid organ transplant patients: clinical features and usefulness of conventional diagnostic tests.Bacterial infections in liver cirrhosis.Sustained low diffusing capacity in hepatopulmonary syndrome after liver transplantation.Genetic variants of innate immune receptors and infections after liver transplantation.Liver transplantation and quality of life.Severity of liver disease affects HCV kinetics in patients treated with intravenous silibinin monotherapySepsis in cirrhosis: report on the 7th meeting of the International Ascites Club.Current management of biliary complications after liver transplantation: emphasis on endoscopic therapy.Treatment options in patients with decompensated cirrhosis, pre- and post-transplantation.ATG-Fresenius treatment and low-dose tacrolimus: results of a randomized controlled trial in liver transplantation.Should IFN-γ, IL-17 and IL-2 be considered predictive biomarkers of acute rejection in liver and kidney transplant? Results of a multicentric study.Use of artificial intelligence as an innovative donor-recipient matching model for liver transplantation: results from a multicenter Spanish study.Hemodynamic evaluation of the patient with portal hypertension.Simple prediction of long-term clinical outcomes in patients with mild hepatitis C recurrence after liver transplantation.Experience with cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis.Invasive pulmonary aspergillosis in solid organ and bone marrow transplant recipients.Rolling review: the treatment of major complications of cirrhosis.Spontaneous bacterial peritonitis in liver cirrhosis: treatment and prophylaxis.A cluster of fever and hypotension on a surgical intensive care unit related to the contamination of plasma expanders by cell wall products of Bacillus stearothermophilus.Prevalence and prognostic value of hepatocellular carcinoma in cirrhotic patients presenting with spontaneous bacterial peritonitis.Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation.Rapidity of fibrosis progression in liver transplant recipients with recurrent hepatitis C is influenced by toll-like receptor 3 polymorphism.Usefulness of liver stiffness measurement during acute cellular rejection in liver transplantation.Bacterial infections in liver disease.Prospective validation of ab initio liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection.Clinical features and outcomes of tuberculosis in transplant recipients as compared with the general population: a retrospective matched cohort study.HEV infection in two referral centers in Spain: epidemiology and clinical outcomes.Treatment of type 2 hepatorenal syndrome in patients awaiting transplantation: Effects on kidney function and transplantation outcomes.Management of ascites in the patient with portal hypertension with emphasis on spontaneous bacterial peritonitis.Epidemiology, clinical characteristics, and outcome of invasive aspergillosis in renal transplant patients.IFNL4 polymorphism predicts response to hepatitis C treatment after liver transplantation.HCV-induced immune responses influence the development of operational tolerance after liver transplantation in humans.Candida norvegensis fungemia in a liver transplant recipient.Graft and viral outcomes in retransplantation for hepatitis C virus recurrence and HCV primary liver transplantation: a case-control study.Liver stiffness 1 year after transplantation predicts clinical outcomes in patients with recurrent hepatitis C.Opportunistic pulmonary infections in solid organ transplant recipients.Protective Effect of Intravenous High Molecular Weight Polyethylene Glycol on Fatty Liver PreservationRestricted use of albumin for spontaneous bacterial peritonitis
P50
Q28274859-2BDA00F2-DD6F-4A49-B6BB-3B2F683E0E6DQ28286264-2867B81F-FCCF-4A43-8AF4-CF5FB5F5F7B9Q33375299-87061430-5233-4D53-9759-08C8240DF4CFQ33798662-0DAC05D5-27B8-4E85-9363-A8C46020AF36Q33909839-1FEAAE5B-0CC1-4A5E-BDCA-A64E25E3F782Q34093766-18F08DD7-2785-4378-8852-D52240E74762Q34143421-B4DDFB4E-F073-41EB-B02E-40FAEA39C505Q34675037-3902104E-28F7-49FD-95F4-CDBB22B3677BQ35597315-9891B99D-6911-4707-98CD-4FA823802BEFQ37778610-4BA08499-A26A-4011-9B2A-10B662AA9059Q38274452-3C05BCFC-6F1E-46D5-8B7C-550752A3284BQ38499334-82BD8A86-62BC-4091-BD62-657CA153844AQ39149234-CD820CFD-BC81-4EDD-A027-11A831C8927AQ39179560-5257BF91-D065-4834-9ECC-4E0CA509870DQ39756174-0CB934E3-6285-4E19-9A2B-84537D59EA42Q40217578-09748079-A9D2-497E-B65D-CF168693862BQ40431048-32BE74E6-05E3-4C39-885A-390D6B950820Q40489747-C040B69C-7EEE-493A-9BAA-5EC8726E2694Q40493607-705A2539-73AD-4644-9315-F4C26B5A7371Q40584335-346F5A42-6FC7-4D0A-820D-4CC8BEC3546CQ40684126-7A62517A-0E26-47B6-BA60-F91F41C8AFA6Q40744480-0B685F17-4493-4585-9AA6-1464794303BEQ40780181-F07FC85A-2909-4ACF-9BB5-848069FD394EQ40787483-0CF0DD31-804F-4D06-AABD-46FD767FF776Q40894137-02ABACAC-F0D7-45D0-826C-86AD9486FBCDQ40910172-E9CC7FBD-0390-4354-A55C-831B0E0D6A69Q41124464-C4A08253-A493-4B85-9090-786EA02A8406Q41325788-D4C0C3CE-47F9-46D8-91AA-BC192C0DDA8EQ41534430-09A8D10D-C06C-4FCF-B6DA-5852C5DF9A33Q41584023-FD736D7C-AED1-4E6E-823E-1D9B3CE806B4Q41635044-92767002-3DF9-4F71-8977-80FA8A4DB1D3Q41700108-F21BA7D3-8124-4B7D-9369-1BB97D7A50D8Q42199557-3B8ECA0B-EEBF-415A-9B1E-CBF3A42279DDQ42210078-984F86D3-08F6-40B8-9678-98649DB5283BQ42216716-AB21F1E1-9776-467D-B609-56BF15AE9EA9Q42220066-6B54F502-CB6E-4BB4-BED3-89FCD45F0C06Q42244049-D9012AD5-6F54-4E95-853E-5715674C6D2FQ42286812-74329598-B24D-466A-80E3-9391F2A9DB42Q42598979-8A8FAEE9-7461-43B3-B6A5-ABB9CA6B67D7Q42843083-A19A425E-B9D9-41B7-B252-844C490ACF53
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
研究者
@zh
name
M A Navasa
@ast
M A Navasa
@en
M A Navasa
@es
M A Navasa
@nl
type
label
M A Navasa
@ast
M A Navasa
@en
M A Navasa
@es
M A Navasa
@nl
prefLabel
M A Navasa
@ast
M A Navasa
@en
M A Navasa
@es
M A Navasa
@nl
P214
P214
P31
P496
0000-0002-3130-9604
P7859
lccn-n00120663